> For the complete documentation index, see [llms.txt](https://assets-web3-or-or-ortusol-intern.gitbook.io/ortusol-international-oca-token-docs/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://assets-web3-or-or-ortusol-intern.gitbook.io/ortusol-international-oca-token-docs/the-campaign/projected-profitability.md).
# Projected profitability
From AssetsWeb3 and Ortusol International, we cannot guarantee a fixed profitability, as this depends on multiple external factors, especially fluctuations in the CBD cannabis market prices at the time of commercialization.
However, our projections are not speculative, as they are 100% supported by hard data, including:
* Pre-approved sales contracts, where there is a commercial relationship that assures demand and competitive prices.
* Results from our production pilot, validating operating costs, agricultural yields and supply chain efficiency.
These elements give us high confidence in our estimates, although it is essential to understand that they remain projections and can be adjusted according to market and operating conditions. Our commitment is to maximize profitability and continually optimize each stage of the process to offer the best possible return to our investors.
Based on historical profitability and the basis for estimating projections, we have defined the following scenario:
| Profit and Loss |
|
|
|
|
|
|
| ----------------------------------------------------------------------- | -------------- | -------------- | -------------- | -------------- | -------------- | -------------- |
|
| Project Year 1 | Project Year 2 | Project Year 3 | Project Year 4 | Project Year 5 | Project Year 6 |
| ORTUSOL LIMITED | Dec-25 | Dec-26 | Dec-27 | Dec-28 | Dec-29 | Dec-30 |
| Total Income | 61.446 | 9.133.817 | 23.110.143 | 45.035.540 | 84.063.504 | 101.313.504 |
| Total Cost of Sales | 334.150 | 437.400 | 863.400 | 1.705.400 | 2.557.400 | 2.567.400 |
| Gross Profit | -272.704 | 8.696.417 | 22.246.743 | 43.330.140 | 81.506.104 | 98.746.104 |
| Total Operating Expenses | 1.198.607 | 1.809.897 | 2.793.674 | 4.938.157 | 7.289.659 | 7.414.493 |
| Earnings before Interest, Tax, Depreciation, Amortization, Amortization | -1.471.311 | 6.886.519 | 19.453.069 | 38.391.984 | 74.216.445 | 91.331.611 |
| Interest, depreciation and amortization | 1.206.344 | 1.206.344 | 1.186.344 | 1.186.344 | 1.182.791 | 857.058 |
| Profit before Tax | -2.677.655 | 5.680.175 | 18.266.725 | 37.205.640 | 73.033.653 | 90.474.553 |
| Tax (25%) |
| 750.630 | 4.566.681 | 9.301.410 | 18.258.413 | 22.618.638 |
| Net Profit | -2.677.655 | 4.929.545 | 13.700.044 | 27.904.230 | 54.775.240 | 67.855.915 |
|
|
|
|
|
|
|
|
| 70% Dividends to distributed |
| 3.450.682 | 9.590.031 | 19.532.961 | 38.342.668 | 47.499.140 |
| 70% Ortusol |
| 2.415.477 | 6.713.022 | 13.673.073 | 26.839.868 | 33.249.398 |
| 30% RWA Investor |
| 1.035.205 | 2.877.009 | 5.859.888 | 11.502.800 | 14.249.742 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total Dividends Received (RWA Investors) |
| 35.524.645 |
|
|
|
|
|
|
|
|
|
|
|
|